Article Versions Notes

Chaparro M, Baston-Rey I, Fernández Salgado E, González García J, Ramos L, Diz-Lois Palomares MT, Argüelles-Arias F, Iglesias Flores E, Cabello M, Rubio Iturria S, et al. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab. Journal of Clinical Medicine. 2022; 11(15):4518. https://doi.org/10.3390/jcm11154518

Chaparro, María, Iria Baston-Rey, Estela Fernández Salgado, Javier González García, Laura Ramos, María Teresa Diz-Lois Palomares, Federico Argüelles-Arias, Eva Iglesias Flores, Mercedes Cabello, Saioa Rubio Iturria, and et al. 2022. "Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab" Journal of Clinical Medicine 11, no. 15: 4518. https://doi.org/10.3390/jcm11154518

Chaparro, M., Baston-Rey, I., Fernández Salgado, E., González García, J., Ramos, L., Diz-Lois Palomares, M. T., Argüelles-Arias, F., Iglesias Flores, E., Cabello, M., Rubio Iturria, S., Núñez Ortiz, A., Charro, M., Ginard, D., Dueñas Sadornil, C., Merino Ochoa, O., Busquets, D., Iyo, E., Gutiérrez Casbas, A., Ramírez de la Piscina, P., ... Gisbert, J. P. (2022). Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab. Journal of Clinical Medicine, 11(15), 4518. https://doi.org/10.3390/jcm11154518